Dr. Xiaohui Zhang, MD

Dr. Zhang practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Zhang's NPI, 1548422900, was assigned on June 27, 2008. Dr. Zhang graduated from Fourth Military Medical University in 1993. Dr. Zhang holds Florida license ME110483.

Dr. Zhang's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Zhang's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Zhang to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 2 sites in all. Vendor and product names are available with a free account.

Anatomic pathology and clinical pathology is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 207ZP0102X. Dr. Zhang is board certified in hematopathology by the American Board of Pathology. Dr. Zhang is licensed in Florida.

CMS data shows 2,986 Medicare services from Dr. Zhang across 19 procedure codes in 2024, for 645 Medicare patients. Medicare paid $71,761 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 645 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 329 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 3.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 68, with 47% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Zhang for performance year 2024, reported as part of a group. Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 43 papers to Dr. Zhang, published from 2005 to 2024. 2014 was the busiest year, with 4. The most frequent topics are Myelodysplastic Syndromes, Cell Line, Tumor and Bone Marrow. Dr. Zhang has published most often in Am J Clin Pathol. Dr. Zhang's most frequent co-authors are Jinming Song, MD, Jeffrey E. Lancet, MD and Haipeng Shao, MD, PhD.

CMS Open Payments shows 2 general payments to Dr. Zhang from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. Stemline Therapeutics Inc. paid the most, $67.

Dr. Zhang graduated from Fourth Military Medical University in 1993.

Dr. Zhang is in network with 2 carriers, including Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.